MISSISSAUGA, ON, Oct. 18, 2013 /CNW/ - Novo Nordisk today announced that Health Canada has approved Levemir ® FlexTouch ®, a disposable prefilled insulin pen containing Levemir ® (insulin detemir).
The US Food and Drug Administration (FDA) has approved Novo Nordisk's prefilled insulin pens NovoLog (insulin aspart [rDNA origin] injection) FlexTouch and Levemir (insulin detemir [rDNA origin] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback